[Use of megazol for the treatment of trypanosomiasis].
Bouteille
B
B
l'Institut d'Epidémiologie Neurologique et de Neurologie Tropicale, Faculté de Médecine, Université de Limoges, France. ient@unilim.fr
Chauviere
G
G
D000083:Acetanilides / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D000890:Anti-Infective Agents / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use; D004195:Disease Models, Animal; D004353:Drug Evaluation, Preclinical; D006801:Humans; D008795:Metronidazole / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use; D051379:Mice; D009593:Nitroimidazoles / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use; D013830:Thiadiazoles / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D014344:Trypanocidal Agents / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D014352:Trypanosomiasis / Q000188:drug therapy* / Q000453:epidemiology / Q000469:parasitology
D000083:Acetanilides; D000890:Anti-Infective Agents; D009593:Nitroimidazoles; D013830:Thiadiazoles; D014344:Trypanocidal Agents; D008795:Metronidazole; C013378:megazol; C038307:fexinidazole; C054646:Ro 15-0216